U.S was Bausch Health Companies’s largest region in fiscal 2025, bringing in $6.14B of $10.27B (60%).
| Geography | FY 2009 | FY 2010 | FY 2011 | FY 2012 | FY 2013 | FY 2014 | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| U.S | — | $5.19B | $5.77B | $6.14B | |||||||||||||
| U.S. & Puerto Rico | $4.84B | — | — | — | |||||||||||||
| Other | $887.00M | $1.01B | $1.08B | $1.15B | |||||||||||||
| Other Europe, Asia, The Middle East, Latin America, Africa & Other | — | — | — | — | |||||||||||||
| Revenues | — | — | — | — | |||||||||||||
| China | $413.00M | $441.00M | $496.00M | $493.00M | |||||||||||||
| Canada | $351.00M | $366.00M | $402.00M | $417.00M | |||||||||||||
| Poland | $278.00M | $319.00M | $350.00M | $382.00M | |||||||||||||
| Mexico | $276.00M | $322.00M | $315.00M | $278.00M | |||||||||||||
| Japan | $200.00M | $194.00M | $188.00M | $192.00M | |||||||||||||
| France | $203.00M | $214.00M | $230.00M | $249.00M | |||||||||||||
| Egypt | — | — | — | — | |||||||||||||
| Russia | $181.00M | $148.00M | $161.00M | $198.00M | |||||||||||||
| Germany | $147.00M | $152.00M | $159.00M | $176.00M | |||||||||||||
| Australia | — | — | — | — | |||||||||||||
| United Kingdom | $115.00M | $125.00M | $135.00M | $141.00M | |||||||||||||
| U.K | — | — | — | — | |||||||||||||
| South Korea | $77.00M | $93.00M | $146.00M | $234.00M | |||||||||||||
| Brazil | — | — | — | — | |||||||||||||
| Spain | $84.00M | $92.00M | $99.00M | $109.00M | |||||||||||||
| Serbia | — | — | — | — | |||||||||||||
| Italy | $76.00M | $86.00M | $94.00M | $106.00M | |||||||||||||
| Total | $8.12B | $8.76B | $9.63B | $10.27B |
Bausch Health Companies brought in $10.27B from its 14 regions in fiscal 2025, the year ended December 31, 2025. That was up 6.7% from $9.63B in fiscal 2024. U.S was the largest at $6.14B (59.8%), ahead of Other at $1.15B (11.2%) and China at $493.00M (4.8%). The other 11 regions brought in $2.48B combined.
Compared with fiscal 2024, South Korea grew fastest, up 60.3% to $234.00M, while Mexico fell the most, down 11.7% to $278.00M.
Bausch Health Companies began breaking out U.S in fiscal 2023, when it brought in $5.19B. Bausch Health Companies stopped reporting U.S. & Puerto Rico as a separate region after fiscal 2022, when it brought in $4.84B.
Bausch Lomb/ International was Bausch Health Companies’s largest segment in fiscal 2017, bringing in $4.87B of $8.72B (56%).
| Segment | FY 2010 | FY 2012 | FY 2013 | FY 2014 | FY 2015 | FY 2016 | FY 2017 |
|---|---|---|---|---|---|---|---|
| Bausch Lomb/ International | — | $4.94B | $4.93B | $4.87B | |||
| Bausch Lomb/International | $4.86B | — | — | — | |||
| Developed Markets | — | — | — | — | |||
| Branded Rx | $1.59B | $3.25B | $2.83B | $2.48B | |||
| U.S. Diversified Products | $1.75B | $2.26B | $1.92B | $1.38B | |||
| Emerging Markets | — | — | — | — | |||
| Revenues | — | — | — | — | |||
| Total | $8.21B | $10.45B | $9.67B | $8.72B |
Bausch Health Companies brought in $8.72B from its three segments in fiscal 2017, the year ended December 31, 2017. That was down 9.8% from $9.67B in fiscal 2016. Bausch Lomb/ International was the largest at $4.87B (55.8%), ahead of Branded Rx at $2.48B (28.4%) and U.S. Diversified Products at $1.38B (15.8%).
Compared with fiscal 2016, every segment above 2% of revenue shrank. Bausch Lomb/ International held up best, down 1.1% to $4.87B, and U.S. Diversified Products fell the most, down 28.2% to $1.38B.
Bausch Health Companies began breaking out Bausch Lomb/ International in fiscal 2015, when it brought in $4.94B. Bausch Health Companies stopped reporting Bausch Lomb/International as a separate segment after fiscal 2014, when it brought in $4.86B.
Previously Reported was Bausch Health Companies’s largest revenue line in fiscal 2015, bringing in $7.71B of $7.69B (100%).
| Statement Scenario | FY 2014 | FY 2015 | FY 2015 | FY 2015 |
|---|---|---|---|---|
| Previously Reported | $5.98B | $2.19B | $4.92B | $7.71B |
| Restatement Adjustments | -$12.90M | -$20.80M | -$20.80M | -$20.80M |
| Total | $5.97B | $2.17B | $4.90B | $7.69B |
Bausch Health Companies brought in $7.69B from its two revenue lines in fiscal 2015, the year ended September 30, 2015. That was up 56.8% from $4.90B in fiscal 2015. Previously Reported was the largest at $7.71B (100.3%).
The total is net of Restatement Adjustments, which took $20.80M off revenue in fiscal 2015.
Bausch Health Companies (BHC) reports its revenue by geography, by segment and by statement scenario. In fiscal 2025, U.S was its largest region, bringing in $6.14B (59.8% of the total), followed by Other at $1.15B (11.2%).
U.S was Bausch Health Companies' largest region in fiscal 2025, bringing in $6.14B, or 59.8% of the $10.27B total across its 14 regions.
Bausch Lomb/ International was Bausch Health Companies' largest segment in fiscal 2017, bringing in $4.87B, or 55.8% of the $8.72B total across its three segments.
Previously Reported was Bausch Health Companies' largest revenue line in fiscal 2015, bringing in $7.71B, or 100.3% of the $7.69B total across its two revenue lines.
Among Bausch Health Companies' regions that make up at least 2% of revenue, South Korea grew fastest in fiscal 2025, up 60.3% from $146.00M to $234.00M.
Every figure comes from Bausch Health Companies' annual financial filings, as reported. Each line keeps the name Bausch Health Companies gives it, and years follow its fiscal calendar.
Bausch Health Companies' revenue by geography goes back to fiscal 2009, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.